<DOC>
	<DOCNO>NCT01382303</DOCNO>
	<brief_summary>This multi-center , randomize control study aim evaluate effect pentoxifylline proteinuria Korean type 2 diabetic patient .</brief_summary>
	<brief_title>Effect Pentoxifylline Proteinuria Korean Type 2 Diabetic Patients</brief_title>
	<detailed_description>The investigator recruit adult patient type 2 diabetes age 20 year spot urine albumin creatinine ratio 30mg/g two consecutive measurement . Enrolled patient randomly assign receive pentoxifylline ( 400mg three time daily ) placebo 24 week . Fasting blood spot urine collect baseline , 12 week 24 week . The investigator evaluate impact pentoxifylline proteinuria type 2 diabetic patient .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>type 2 diabetes mellitus age &gt; =20 year spot urine albumin/creatinine ratio &gt; 30mg/g two consecutive measurement patient ACEinhibitor ARB antihypertensive drug blood pressure &lt; = 150/100 mmHg HbA1c &lt; 10 % take insulin pentoxifylline , cilostazol , ketas , viagra 3 month ischemic heart disease , stroke , malignant disease , severe infection 6 month serum creatinine &gt; 2.0mg/dl severe liver disease AST , ALT &gt; 3* ULM take systemic steroid 1 month pregnant plan become pregnant clinical trial lactation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>pentoxifylline</keyword>
	<keyword>proteinuria</keyword>
</DOC>